( NYSE:GSK )

News from GSK A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 14, 2017, 10:00 ET New survey shines light on critical gaps in adult vaccination knowledge

Even though vaccines are one of the greatest health innovations of the last century, a new survey shows that among some adults in America there is...


Nov 07, 2017, 12:00 ET GSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose

GSK today announced results from BLISS-SC, a 52-week study for BENLYSTA (belimumab) for subcutaneous use (SC) in adult patients with active,...


Nov 06, 2017, 11:00 ET New GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management

Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for...


Oct 25, 2017, 13:52 ET CDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up

GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on...


Oct 20, 2017, 19:16 ET Shingrix approved in the US for prevention of shingles in adults aged 50 and over

GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine...


Sep 13, 2017, 15:49 ET FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food...


Jul 21, 2017, 15:18 ET GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosus

GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the...


Jul 14, 2017, 16:56 ET GSK ships 2017-18 seasonal influenza vaccines for US market

GSK (LSE/NYSE: GSK) today announced it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and...


Jun 21, 2017, 11:19 ET GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting

GSK (LSE/NYSE: GSK) today will be presenting new results from a clinical study showing that its candidate vaccine for the prevention of herpes...


May 01, 2017, 10:05 ET GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for...


Mar 15, 2017, 11:13 ET GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration...


Mar 06, 2017, 10:20 ET GSK's MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype

GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic...


Jan 19, 2017, 09:30 ET GSK Announces Winners of 2016 Discovery Fast Track Boston Challenge

GSK has named two academic researchers winners of the 2016 Discovery Fast Track Boston Challenge. The Challenge is sponsored by GSK's Discovery...


Nov 21, 2016, 08:28 ET GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and...


Nov 16, 2016, 11:14 ET GSK's Benlysta® (belimumab) Shows Sustained Benefits in Patients with SLE

Results from 7-year Phase III continuation study in US patients GSK today announced results from a 7-year safety and efficacy continuation study...


Nov 14, 2016, 10:28 ET GSK Announces Positive Results in Fourth Consecutive Pivotal Trial of Benlysta® (belimumab) in SLE

Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta GSK today announced positive efficacy and...


Oct 27, 2016, 09:11 ET GSK presents new data for shingles candidate vaccine at IDWeek scientific conference

GSK today announced new data for its shingles candidate vaccine Shingrix™, at the Infectious Disease Week (IDWeek) scientific conference in New...


Sep 14, 2016, 17:38 ET GSK's candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM

GSK (LSE/NYSE: GSK) today announced the publication of detailed results from a randomised phase III study (ZOE-70) of its investigational shingles...


Aug 05, 2016, 11:00 ET GSK unveils campaign to help prevent meningitis

GSK (LSE: GSK) today launched an educational campaign to help raise awareness of meningitis, a rare but potentially deadly disease. Most teens and...


Jul 20, 2016, 15:51 ET GSK ships 2016-17 seasonal influenza vaccines for US market

 GSK [LSE/NYSE: GSK] announced today it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and...


May 03, 2016, 08:00 ET National survey of uncontrolled asthma patients finds majority mistakenly believe their asthma is under control

 GSK today released data from a new national survey of more than 1,000 uncontrolled asthma patients showing that 67% of adults with...


Nov 24, 2014, 09:00 ET Las familias y la influenza: Lo que necesita saber

La actividad de la influenza, por lo general, aumenta alrededor de noviembre y alcanza el pico entre diciembre y febrero. Hay medidas...


Nov 13, 2014, 15:18 ET Families and Flu: What You Need to Know Now

Flu activity typically increases around November and peaks between December and February.  Simple steps can lower the risks of...


Nov 11, 2014, 10:00 ET GSK Survey Points to Rise of COPD in US

 As patients, caregivers and the healthcare community come together in support of World COPD Day (November 19), a GSK global survey of people...


Nov 06, 2014, 11:37 ET Barriers remain in educating people with diabetes of their increased hepatitis B risk

 Diabetes educators cite a lack of time and competing priorities during counseling sessions with patients as key barriers to educating their...